"The Seattle Arthritis Clinic at UW Medical Center - Northwest is a multidisciplinary clinic comprised of experts specializing in the medical diagnosis and treatment of musculoskeletal and inflammatory illnesses, including rheumatoid arthritis, lupus, osteoporosis and many others. Common problems such as tendonitis, back pain, bursitis and carpel tunnel syndrome can be a result of rheumatologic disorders as well. In addition to board-certified rheumatologists, our care team includes rheumatology nurse practitioners, a mental health counselor, psychologist and a nutritionist who all work together to care for you as a whole person."

During the past decade, The Seattle Arthritis Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 7 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Seattle Arthritis Clinic" #1 sponsor was "Pfizer" with 3 trials, followed by "Genzyme, a Sanofi Company" with 2 trials sponsored, "Human Genome Sciences Inc." with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Seattle Arthritis Clinic" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Seattle Arthritis Clinic" are "Rheumatoid Arthritis" (4 trials), "Arthritis, Rheumatoid" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Musculoskeletal Diseases" (1 trials). Many other conditions were trialed in "The Seattle Arthritis Clinic" in a lesser frequency.

Most popular intervention types in "The Seattle Arthritis Clinic" are "Drug" (8 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials), "Baricitinib" (1 trials) and "Baricitinib Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Seattle Arthritis Clinic" are 12 trials for "All" genders.

Currently, there are NaN active trials in "The Seattle Arthritis Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in The Seattle Arthritis Clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Seattle Arthritis Clinic, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".